Company Profile
Onconova Therapeutics Stock Price, News & Catalysts
- Ticker:
- ONTX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
16.35 USD (-7.06%)
Close
Last updated: August 24, 2026
—
Market cap
Why the stock is moving
As of Aug 24, 2026, ONTX closed down 7.06% at $16.35. No new same-company headline was identified in the current news window.
Company overview
Business overview
Onconova Therapeutics is a development-stage oncology company focused on targeted cancer therapies and precision approaches to hard-to-treat malignancies. Its investment case comes from the possibility that a small set of programs can generate meaningful clinical and strategic value.
Geographic Base and Sector Classification
Onconova is headquartered in the United States and listed on NASDAQ, with a small-cap oncology biotech profile. It sits in the classic development-stage cancer-therapeutics category.
Business Model Characteristics
The business depends on clinical progress, regulatory optionality, and capital preservation. Investors usually focus on proof-of-concept data, pipeline prioritization, and whether the company can extend its runway long enough to create value.
Position Within the Biotechnology Landscape
Onconova occupies a highly volatile oncology niche within biotech. Like many small cancer-drug developers, its stock can reprice sharply around data, financing, or partnership news.
Future catalysts
- Onconova is another legacy closeout name, with catalysts limited to any strategic or asset-disposition update. The market is mainly waiting for what value remains.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Onconova Therapeutics (ONTX)?
Onconova Therapeutics (ONTX) most recently closed at 16.35 USD, a -7.06% move versus the previous session.
What does Onconova Therapeutics do?
Onconova Therapeutics is a development-stage oncology company focused on targeted cancer therapies and precision approaches to hard-to-treat malignancies. Its investment case comes from the possibility that a small set of programs can generate meaningful clinical and strategic value.
On which exchange is ONTX stock listed?
Onconova Therapeutics (ONTX) is associated with NASDAQ, United States, Biopharma.
What is Onconova?
Onconova is another legacy closeout name, with catalysts limited to any strategic or asset-disposition update.
Which conditions is Onconova Therapeutics targeting with Onconova?
Onconova Therapeutics is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Onconova Therapeutics describe recent progress with Onconova?
Onconova is another legacy closeout name, with catalysts limited to any strategic or asset-disposition update.
What is Therapeutics?
Onconova Therapeutics is a development-stage oncology company focused on targeted cancer therapies and precision approaches to hard-to-treat malignancies.
What should investors watch for with Therapeutics?
Onconova is another legacy closeout name, with catalysts limited to any strategic or asset-disposition update. The market is mainly waiting for what value remains.